Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

Also called NCT01366482

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 121 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01366482
Other papers using this trial's data
  • Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study Circulation. Cardiovascular interventions, 2017-09 DOI, PubMed 28916599, PMC5610565 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01366482. Randomized; double masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease
Acronym
DEFINITIVE AR
Condition
Peripheral Arterial Disease
Condition
Claudication
Intervention (Device)
Cotavance Drug-Eluting Balloon
Intervention (Device)
TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon
Intervention (Device)
TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon
Lead sponsor
Medtronic Endovascular (class: industry)
Collaborator
MEDRAD, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01366482
Content hash
4d5ec0ac42c3cdb948909e9f6794476452319b9955064962d1ba5ba2f342f262